ADC Therapeutics SA Current Lease Liabilities
ADC Therapeutics SA (ADCT) had Current Lease Liabilities of $1.42 million as of 2023-09-30, per its 6-K filed 2023-11-07.
Discontinued › Notes › Leases
ifrs-full:CurrentLeaseLiabilities · last filed 2023-11-07
- 2023-09-30: Current Lease Liabilities $1.42M.
- 2023-06-30: Current Lease Liabilities $1.63M.
- 2023-03-31: Current Lease Liabilities $1.45M.
- 2022-12-31: Current Lease Liabilities $1.10M.
| Period end | Current Lease Liabilities | Current Lease Liabilities as first filed |
|---|---|---|
| 2023-09-30 | $1.42M 6-K · filed 2023-11-07 | |
| 2023-06-30 | $1.63M 6-K · filed 2023-08-08 | |
| 2023-03-31 | $1.45M 6-K · filed 2023-05-09 | |
| 2022-12-31 | $1.10M 6-K · filed 2023-11-07 | |
| 2022-09-30 | $835.00K 6-K · filed 2023-11-07 | |
| 2022-06-30 | $909.00K 6-K · filed 2023-08-08 | |
| 2022-03-31 | $981.00K 6-K · filed 2023-05-09 | |
| 2021-12-31 | $1.03M 20-F · filed 2023-03-15 | |
| 2021-09-30 | $1.01M 6-K · filed 2022-11-08 | |
| 2021-06-30 | $988.00K 6-K · filed 2022-08-09 | |
| 2021-03-31 | $833.00K 6-K · filed 2022-05-09 | |
| 2020-12-31 | $1.00M 20-F · filed 2022-03-17 | |
| 2020-09-30 | $1.05M 6-K · filed 2021-11-02 | |
| 2020-06-30 | $1.10M 6-K · filed 2021-08-03 | |
| 2020-03-31 | $1.12M 6-K · filed 2021-05-06 | |
| 2019-12-31 | $924.00K 20-F · filed 2022-03-17 | $1.13M 20-F · filed 2021-03-18 |
| 2019-01-01 | $924.00K 20-F · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |